Table 3: Treatment Regimens Used for KS Patients.
|
AIDS-KS |
CKS |
Immunosuppression therapy-related KS |
Stage of disease |
|||
Localized |
74 (77.9%) |
29 (93.5%) |
4 (100%) |
Metastatic |
21 (22.1%) |
2 (6.5%) |
0 |
Treatment |
|||
HAART |
41 (43.2%) |
0 |
0 |
Observation |
0 |
13(41.9%) |
0 |
Chemotherapy |
45(47.4%) |
5(16.1%) |
2 (50%) |
Surgery |
2 (2.1%) |
5 (16.1) |
0 |
Radiation |
3 (3.2%) |
2 (6.5%) |
1 (25%) |
Surgery + Radiation |
0 |
2 (6.5%) |
0 |
Surgery + Radiation + Chemo |
0 |
1 (3.2%) |
0 |
Other/unknown |
4 (4.2%) |
2 (6.5%) |
1 (25%) |